Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Another analysis of the ACCORD-MIND trial has associated intensive glycemic therapy with potential changes in the brain of patients with type 2 diabetes.
Although previous research demonstrates that treatment-related hypoglycemia has little effect on the brain, the type of therapy may actually play a role.
These findings shed light on how different diabetes therapies may affect the brain.
Related Content
READ FULL ARTICLE
From Diabetesjournals
